Skip to main content
Journal cover image

Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.

Publication ,  Journal Article
Henson, JB; Patel, YA; King, LY; Zheng, J; Chow, S-C; Muir, AJ
Published in: Liver Transpl
June 2017

Liver retransplantation in patients with primary sclerosing cholangitis (PSC) has not been well studied. The aims of this study were to characterize patients with PSC listed for and undergoing retransplantation and to describe the outcomes in these patients. The United Network for Organ Sharing/Organ Procurement and Transplantation Network database was used to identify all primary liver transplantations and subsequent relistings and first retransplantations in adults with PSC between 1987 and 2015. A total of 5080 adults underwent primary transplantation for PSC during this period, and of the 1803 who experienced graft failure (GF), 762 were relisted, and 636 underwent retransplantation. Younger patients and patients with GF due to vascular thrombosis or biliary complications were more likely to be relisted, whereas those with Medicaid insurance or GF due to infection were less likely. Both 5-year graft and patient survival after retransplantation were inferior to primary transplantation (P < 0.001). Five-year survival after retransplantation for disease recurrence (REC), however, was similar to primary transplantation (graft survival, P = 0.45; patient survival, P = 0.09) and superior to other indications for retransplantation (graft and patient survival, P < 0.001). On multivariate analysis, mechanical ventilation, creatinine, bilirubin, albumin, advanced donor age, and a living donor were associated with poorer outcomes after retransplantation. In conclusion, although survival after liver retransplantation in patients with PSC was overall inferior to primary transplantation, outcomes after retransplantation for PSC REC were similar to primary transplantation at 5 years. Retransplantation may therefore represent a treatment option with the potential for excellent outcomes in patients with REC of PSC in the appropriate clinical circumstances. Liver Transplantation 23 769-780 2017 AASLD.

Duke Scholars

Published In

Liver Transpl

DOI

EISSN

1527-6473

Publication Date

June 2017

Volume

23

Issue

6

Start / End Page

769 / 780

Location

United States

Related Subject Headings

  • Waiting Lists
  • United States
  • Treatment Outcome
  • Time Factors
  • Surgery
  • Risk Factors
  • Respiration, Artificial
  • Reoperation
  • Recurrence
  • Multivariate Analysis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Henson, J. B., Patel, Y. A., King, L. Y., Zheng, J., Chow, S.-C., & Muir, A. J. (2017). Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. Liver Transpl, 23(6), 769–780. https://doi.org/10.1002/lt.24703
Henson, Jacqueline B., Yuval A. Patel, Lindsay Y. King, Jiayin Zheng, Shein-Chung Chow, and Andrew J. Muir. “Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.Liver Transpl 23, no. 6 (June 2017): 769–80. https://doi.org/10.1002/lt.24703.
Henson JB, Patel YA, King LY, Zheng J, Chow S-C, Muir AJ. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. Liver Transpl. 2017 Jun;23(6):769–80.
Henson, Jacqueline B., et al. “Outcomes of liver retransplantation in patients with primary sclerosing cholangitis.Liver Transpl, vol. 23, no. 6, June 2017, pp. 769–80. Pubmed, doi:10.1002/lt.24703.
Henson JB, Patel YA, King LY, Zheng J, Chow S-C, Muir AJ. Outcomes of liver retransplantation in patients with primary sclerosing cholangitis. Liver Transpl. 2017 Jun;23(6):769–780.
Journal cover image

Published In

Liver Transpl

DOI

EISSN

1527-6473

Publication Date

June 2017

Volume

23

Issue

6

Start / End Page

769 / 780

Location

United States

Related Subject Headings

  • Waiting Lists
  • United States
  • Treatment Outcome
  • Time Factors
  • Surgery
  • Risk Factors
  • Respiration, Artificial
  • Reoperation
  • Recurrence
  • Multivariate Analysis